in any new disease, to understand pathogenesis, as well as to screen for drugs and test for vaccines, animal models are critical. the doctor mentioned the issue of control. there are a number of ways to do that. the classic way but also the novel ways in which we are exploring but should not take the place of the classic way, things like genetic manipulation of mosquitoes and bacteria. again, to emphasize that this is not an easy thing to do as the doctor emphasize. control is important, but it is not easy to implement. we mentioned diagnostics, and the cdc has taken the lead on that, but our contractors are using studies of other viruses to get more precise, state-of-the-art, points of contact, specific diagnosis so women ifan tell they have been infected with zika during a pregnancy or before. importantly, our role in the development of the vaccine is encouraging news, and the reason i say encouraging is because we have had positive experience with the development of vaccines for other viruses. dangue in which there is already in approved vaccine in mexico. this was in collaboration

in any new disease, to understand pathogenesis, as well as to screen for drugs and test for vaccines, animal models are critical. the doctor mentioned the issue of control. there are a number of ways to do that. the classic way but also the novel ways in which we are exploring but should not take the place of the classic way, things like genetic manipulation of mosquitoes and bacteria. again, to emphasize that this is not an easy thing to do as the doctor emphasize. control is important, but it is not easy to implement. we mentioned diagnostics, and the cdc has taken the lead on that, but our contractors are using studies of other viruses to get more precise, state-of-the-art, points of contact, specific diagnosis so women ifan tell they have been infected with zika during a pregnancy or before. importantly, our role in the development of the vaccine is encouraging news, and the reason i say encouraging is because we have had positive experience with the development of vaccines for other viruses. dangue in which there is already in approved vaccine in mexico. this was in collaboration

in any new disease to understand pathogenesis as well as to screen for drugs and test for vaccines, animal models are critical. dr. friedan mentioned the issue of vector control. there are a number of ways to do that. the classic way,s about also some novel ways which we are exploring but should not take the place of the classic ways, things like the genetic manipulation of mosquitos or infection with malbacchia material. to emphasize this is not an easy thing to do. as dr. friedan has emphasized. vector control is a very important tool, but it is not easy to implement. we mentioned diagnostics. the cdc is taking the lead on that our grantees and contractors are using some of the knowledge gained from our study in chikungunya, in dengue and in other, to get more precise, state-of-the-art point of contact specific diagnosis, so we can tell a woman who may not know whether she got infected, whether she actually had been infected with zika during her pregnancy or before. our role in developing a vaccine is encouraging news. and the reason i say encouraging is we've had positive experience wit

in addition, we'll be establishing animal models and any new disease to understand pathogenesis as well as to screen for drugs and test for vaccines, animal models are critical. dr. frieden mentioned the issue of vector control. there are a number of ways to do that. the classic way, but also some novel ways which we are exploring but should not take the place of the classic ways, and that is things like the again nick manipulation of mosquitos or infection with other bacteria. again to emphasize, this is not an easy thing to do, as dr. frieden has emphasized. vector control is a very important tool, but it is not easy to implement. we mentioned diagnostics. the cdc is taking the lead on that, but our grantees and contractors are using some of the knowledge gained from our study in chikungunya, in dengue and other to get more precise state of the art point of contact specific diagnosis so we can tell a woman, who may not know whether she got infected, whether she actually had been infected with zika during her pregnancy, or before. importantly our role in the development of a vaccine is

pregnancy and the development of congenital abnormalities such as microcephaly as well as understanding the pathogenesis the disease. with regards to basic research it is similar to the basic research we have done with other viruses throughout the years ranging from hav 30 plus years ago to most recently with ebola. that is a look at the viral structure, viral pathology, metal -- medical virology. the pathogenesis of the immune response which gives us great insight into the development of vaccines. .. are working on a more sensitive and specific antibody test to determine if, in fact, someone has been infected because we know now the current test that they will have a degree of cross reactivity. one of the most important things we do is develop vaccines as we'vwe've done for so many othef these emerging threats. that candidates you see on the sly, the two marked with red are the two that i most adv >> >> right now i will give you examples light after decades of research with other diseases to give us a head start. years ago we developed the vaccine for west nile virus. we went into phase one to make sur